Correlation Between Pfizer and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Replimune Group, you can compare the effects of market volatilities on Pfizer and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Replimune.

Diversification Opportunities for Pfizer and Replimune

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Replimune is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Pfizer i.e., Pfizer and Replimune go up and down completely randomly.

Pair Corralation between Pfizer and Replimune

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Replimune. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.47 times less risky than Replimune. The stock trades about -0.05 of its potential returns per unit of risk. The Replimune Group is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,256  in Replimune Group on August 31, 2024 and sell it today you would lose (848.00) from holding Replimune Group or give up 37.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Replimune Group

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The new stock price tumult, may contribute to shorter-term losses for the shareholders.
Replimune Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Replimune

The main advantage of trading using opposite Pfizer and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind Pfizer Inc and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope